Form 4: Atlassian Co-Founder Scott Farquhar Sells Over 7,600 Shares Under Pre-Arranged Plan
Insider Trading Report
Atlassian Director and 10% owner Scott Farquhar sold 7,665 shares of Class A Common Stock for approximately $1.5 million through a pre-scheduled Rule 10b5-1 trading plan.
Summary
- Scott Farquhar, a Director and 10% Owner of Atlassian Corp (TEAM), disposed of a total of 7,665 shares of Class A Common Stock on July 23, 2025.
- The sales were executed in multiple trades at weighted-average prices ranging from $197.1322 to $204.583 per share.
- These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Farquhar on February 12, 2025.
- Following these transactions, Mr. Farquhar indirectly beneficially owns 367,920 shares of Class A Common Stock, held by Farquhar Investment Partnership No. 2.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While it involves insider selling, the pre-planned nature of the transactions via a Rule 10b5-1 plan mitigates concerns about opportunistic trading, making it a routine liquidity event rather than a signal of negative company prospects.
Positives
- The stock sales were executed under a pre-arranged Rule 10b5-1 trading plan, which indicates a systematic approach to liquidity management rather than a reaction to recent negative developments or inside information.
Negatives
- Insider selling, even when pre-planned, can sometimes be perceived negatively by the market, potentially leading to a slight downward pressure on share price or investor sentiment.
Risks
- Potential for negative market perception or investor speculation regarding the reasons for insider selling, despite the existence of a Rule 10b5-1 plan.
Future Outlook
No forward-looking statements or guidance regarding the company's financial performance or strategic direction are provided in this filing, as it pertains solely to an insider stock transaction.
Industry Context
Insider stock sales, particularly by founders and key executives in the technology sector, are common for personal financial planning, diversification, and liquidity. The use of a Rule 10b5-1 trading plan is a standard practice that allows insiders to sell shares at pre-determined times or prices, providing an affirmative defense against claims of trading on material non-public information.
Comparison to Industry Standards
- The execution of stock sales through a Rule 10b5-1 plan is a widely accepted and common practice among executives and directors across the technology industry and broader public markets. This method is consistent with corporate governance best practices aimed at mitigating concerns about opportunistic insider trading.
Related Party Transactions
- The shares are held indirectly by Farquhar Investment Partnership No. 2, which is a related entity to the reporting person, Scott Farquhar.
Stakeholder Impact
- Shareholders may observe the insider sale, but the pre-planned nature of the transaction under a Rule 10b5-1 plan should alleviate concerns about the company's immediate prospects. The impact on employees, customers, suppliers, and creditors is likely minimal as this is a personal financial transaction of a director.
Key Dates
| Date | Description |
|---|---|
| February 12, 2025 | Rule 10b5-1 trading plan adopted by Scott Farquhar. |
| July 23, 2025 | Date of stock transactions by Scott Farquhar. |
| July 24, 2025 | Date of SEC Form 4 filing. |
Recommendation
holdThe sale by a co-founder and director, while notable, was conducted under a pre-arranged Rule 10b5-1 trading plan. This suggests a systematic liquidity event rather than a reaction to new negative information. Such planned transactions typically have a neutral to slightly negative impact on sentiment but do not fundamentally alter the investment thesis for Atlassian, warranting a 'hold' recommendation.
Keywords
Atlassian, TEAM, Scott Farquhar, insider trading, stock sale, Form 4, 10b5-1 plan, software, tech
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.